Mother-to-child transmission often led to pretreatment drug resistance and acquired drug resistance in children living with ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

The authors study how apolipoprotein L1 variants impact inflammation and lipid accumulation in macrophages. The findings will be useful for researchers investigating macrophage metabolism and ...

HIV-1 protease inhibitors are unique among anti-HIV-1 drugs in that they have very high potency and they also have a very high genetic barrier to resistance. The viral protease is essential in the ...

Gilead’s twice-a-year HIV prevention drug lenacapavir is 30 years in the making. Here’s the story behind it.

2025-06-18 06:11 banned male enhancement pills what does hiv protease do And the science of ejaculation male enhancement pills used for.

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of preventive management than in the general population.

Data from the DOH showed that 5,101 confirmed cases of HIV were recorded from January to March. The figure is 50 percent higher than the number of cases recorded in the same period last year.

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

Protease inhibitors are antiviral drugs commonly used to treat HIV. Learn about how they work, how effective they are, and more.

Researchers assessed whether switching to protease inhibitor-based antiretroviral therapy mitigates or reverses weight gain in patients with HIV infection.

Understand the progression of HIV treatment over the decades. Learn how advancements have transformed HIV from a deadly disease to a manageable chronic condition.